ReviewSAGE open medicine2024

Cardioprotective effects of sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase 4 inhibitor in type 2 diabetes: A meta-analysis of comparative safety and efficacy.

Abhigan Babu Shrestha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.